Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy
This JAMA Clinical Guidelines Synopsis summarizes the National Comprehensive Cancer Network ’s 2019 guidelines on management of immunotherapy-related toxicities, including adverse skin reaction, colitis, and myocarditis.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Immunotherapy | Myocarditis | Skin | Toxicology